Mayo Clinic Laboratory and pathology research roundup: March 21 - Insights
This week's Research Roundup features: Performance comparisons of methylation and structural variants from low-input whole-genome methylation sequencing.
Mayo Clinic Laboratory and pathology research roundup: March 7 - Insights
This week's Research Roundup features: Membranous nephropathy in syphilis is associated with neuron-derived neurotrophic factor.
Mayo Clinic Laboratory and pathology research roundup: April 4 - Insights
This week's Research Roundup features: Fatal Human Rabies Infection with Suspected Host-mediated Failure of Post-Exposure Prophylaxis Following a Recognized Zoonotic Exposure-Minnesota, 2021.
Mayo Clinic Laboratory and pathology research roundup: April 25 - Insights
This week's Research Roundup feature: Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis.
Mayo Clinic Laboratory and pathology research roundup: May 23 - Insights
This week's research roundup feature: Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Mayo Clinic Laboratory and pathology research roundup: March 14 - Insights
This week's Research Roundup features: Novel through-the-scope suture closure of colonic Endoscopic Mucosal resection defects.
Mayo Clinic Laboratory and pathology research roundup: March 28 - Insights
This week's Research Roundup features: Elementary overview of heavy metals.
Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights
This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.
Mayo Clinic Laboratory and pathology research roundup: September 5 - Insights
This week's research roundup feature: 16S rRNA gene PCR/Sequencing of heart valves for diagnosis of infective endocarditis in routine clinical practice.
Mayo Clinic Laboratory and pathology research roundup: August 15 - Insights
This week's research roundup feature: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.